Daniel Skovronsky
Tracked across 1 events · 6 articles · First seen Sep 16, 2026 · Last active Sep 16, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Altor BioScience Corporation announced an agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company. Under the agreement, Twist will provide antibody characterization data services for TuneLab, including for…
Impact: As Lilly chief scientific officer and president of Lilly Research Laboratories and Lilly Immunology, Daniel Skovronsky framed TuneLab as an equalizer giving smaller companies access to Lilly-grade AI capabilities.
Sep 16, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Daniel Skovronsky live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard